Asurion to Acquire Domestic & General, Establishing a Global Leader in Technology and Appliance Care Committed to Excellence in Customer Service

Asurion to Acquire Domestic & General, Establishing a Global Leader in Technology and Appliance Care Committed to Excellence in Customer Service

The combined company will accelerate Asurion's vision to become CTO of the home, by delivering seamless, intelligent care for every connected device and appliance in the home and making technology simpler, more reliable, and more sustainable for...

Unlocking Festive Memories at The Ritz-Carlton, Bali

Unlocking Festive Memories at The Ritz-Carlton, Bali

A memorable stay package and dining program this festive season at a Bali beachfront resort. BALI, Indonesia, Nov. 26, 2025 /PRNewswire/ -- Experience the enchanting allure of Bali this festive season, where joyful celebrations blend seamlessly with...

Fisher Investments Recognised as a Great Place to Work®

Fisher Investments Recognised as a Great Place to Work®

Fisher Investments was certified by global authority on workplace culture SYDNEY, Nov. 25, 2025 /PRNewswire/ -- Fisher Investments Australia and its US-based parent company, Fisher Investments, were certified by Great Place to Work®, an independent,...

Boqii Holding Limited Announces Closing of $4.2 Million Registered Direct Offering

Boqii Holding Limited Announces Closing of $4.2 Million Registered Direct Offering

SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ), a leading pet-focused platform in China, announced today the closing of a registered direct offering (the "Offering") of approximately $4.2...

CGTN AMERICA & CCTV UN: Global Dialogue on Innovation, Openness and Shared Development

CGTN AMERICA & CCTV UN: Global Dialogue on Innovation, Openness and Shared Development

WASHINGTON, Oct. 23, 2025 /PRNewswire/ -- CGTN America & CCTV UN releases "Global Dialogue on Innovation, Openness and Shared Development" China Media Group will host a media event on Friday, October 24, at the Embassy of the People's Republic...

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Announces Pricing of Initial Public Offering

AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C Announces Pricing of Initial Public Offering

DUBAI, UAE, Oct. 21, 2025 /PRNewswire/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, (the "Company") (NASDAQ: AHMA), a UAE-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced the pricing of...

The Ritz-Carlton, Bali Named as "Indonesia's Best Hotel Spas" in Travel+Leisure Luxury Awards Asia Pacific 2025

The Ritz-Carlton, Bali Named as "Indonesia's Best Hotel Spas" in Travel+Leisure Luxury Awards Asia Pacific 2025

Download image: https://marrstar.box.com/s/0yabr8z44cj6mgma4xwoawyrryikwqhq BALI, Indonesia, June 24, 2025 /PRNewswire/ -- The Ritz-Carlton, Bali, a premier beachfront sanctuary nestled on shores of Bali, is proud to announce its prestigious win as...

Bright Scholar Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Bright Scholar Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

CAMBRIDGE, England and FOSHAN, China, June 20, 2025 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global premier education service company, today announced that the independent special...

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bull

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the...

Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for...

  • 1
  • 2
  • 3
  • menu
    menu